The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Take a look at some of Wednesday's midday movers:
Regeneron moved higher after biotechnology company and Sanofi announced promising Phase 3 trials for their injectable cholesterol drug, Alirocumab. When used by itself, it cut levels of bad LDL cholesterol almost in half.
Abbott Labs gained after the pharmaceutical company reported better-than-expected quarterly earnings, helped by cost cutting and lower taxes. Revenue rose 2 percent to $5.37 billion, a bit less than what the Street was expecting
Sprint climbed after Macquarie upgraded the stock to "outperform" from "neutral" on valuation. The company is also a favorite of hedge fund billionaire Leon Cooperman.
Advance Auto Parts surged to a record high on news it will buy privately-held General Parts for $2 billion, making it the largest North American retailer of auto parts.
Veeva nearly doubled in its market debut, valuing the company at nearly $5 billion. Veeva is a provider of cloud-bases software to drugmakers.
Arch Coal moved lower after Morgan Stanley downgraded the stock to "underweight" from "equal weight" with a price target of $2.
Morgan Stanley also downgraded Exelon to "underweight" from "overweight" with a price target of $21.
Tesla moved higher despite S&P Capital IQ initiating coverage with a "sell" rating and a price target of $150 million, based on valuation.
St Jude Medical reporting a 49 percent increase in third-quarter earnings but the stock slipped, possibly due to lower than expected gross profit margins.
Cisco Systems moved to the downside after MKM Partners downgraded the stock to "neutral" from "buy" as it now longer expects year-over-year product orders to accelerate in the company's fiscal year first quarter.
MKM Partners upgraded Juniper Networks to "buy" from "neutral" as it sees a return to cored spending at service providers.
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at firstname.lastname@example.org